On Friday, Tyra Biosciences Inc (NASDAQ: TYRA) opened higher 7.08% from the last session, before settling in for the closing price of $10.74. Price fluctuations for TYRA have ranged from $9.93 to $29.60 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 4.06% at the time writing. With a float of $32.05 million, this company’s outstanding shares have now reached $52.87 million.
Let’s look at the performance matrix of the company that is accounted for 49 employees. In terms of profitability, gross margin is 30.28%, operating margin of -19938.65%, and the pretax margin is -16681.27%.
Tyra Biosciences Inc (TYRA) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Tyra Biosciences Inc is 39.39%, while institutional ownership is 60.09%. The most recent insider transaction that took place on Feb 05 ’25, was worth 74,324. In this transaction Director of this company sold 5,401 shares at a rate of $13.76, taking the stock ownership to the 443,885 shares. Before that another transaction happened on Feb 05 ’25, when Company’s Director proposed sale 120,000 for $13.75, making the entire transaction worth $1,650,000.
Tyra Biosciences Inc (TYRA) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 4.06% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -11.57% during the next five years compared to -102.86% drop over the previous five years of trading.
Tyra Biosciences Inc (NASDAQ: TYRA) Trading Performance Indicators
Check out the current performance indicators for Tyra Biosciences Inc (TYRA). In the past quarter, the stock posted a quick ratio of 29.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.61, a number that is poised to hit -0.47 in the next quarter and is forecasted to reach -2.01 in one year’s time.
Technical Analysis of Tyra Biosciences Inc (TYRA)
Tyra Biosciences Inc (NASDAQ: TYRA) saw its 5-day average volume 0.56 million, a positive change from its year-to-date volume of 0.3 million. As of the previous 9 days, the stock’s Stochastic %D was 55.72%. Additionally, its Average True Range was 0.84.
During the past 100 days, Tyra Biosciences Inc’s (TYRA) raw stochastic average was set at 7.98%, which indicates a significant decrease from 48.68% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 63.73% in the past 14 days, which was lower than the 71.43% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $13.52, while its 200-day Moving Average is $17.86. Nevertheless, the first resistance level for the watch stands at $12.06 in the near term. At $12.62, the stock is likely to face the second major resistance level. The third major resistance level sits at $13.43. If the price goes on to break the first support level at $10.70, it is likely to go to the next support level at $9.89. The third support level lies at $9.33 if the price breaches the second support level.
Tyra Biosciences Inc (NASDAQ: TYRA) Key Stats
There are currently 50,603K shares outstanding in the company with a market cap of 581.93 million. Presently, the company’s annual sales total 0 K according to its annual income of -69,130 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -24,020 K.
